Literature DB >> 32438095

Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis.

Stephan Ong Tone1, Viridiana Kocaba1, Myriam Böhm2, Adam Wylegala1, Tomas L White1, Ula V Jurkunas3.   

Abstract

Fuchs endothelial corneal dystrophy (FECD) is the most common primary corneal endothelial dystrophy and the leading indication for corneal transplantation worldwide. FECD is characterized by the progressive decline of corneal endothelial cells (CECs) and the formation of extracellular matrix (ECM) excrescences in Descemet's membrane (DM), called guttae, that lead to corneal edema and loss of vision. FECD typically manifests in the fifth decades of life and has a greater incidence in women. FECD is a complex and heterogeneous genetic disease where interaction between genetic and environmental factors results in cellular apoptosis and aberrant ECM deposition. In this review, we will discuss a complex interplay of genetic, epigenetic, and exogenous factors in inciting oxidative stress, auto(mito)phagy, unfolded protein response, and mitochondrial dysfunction during CEC degeneration. Specifically, we explore the factors that influence cellular fate to undergo apoptosis, senescence, and endothelial-to-mesenchymal transition. These findings will highlight the importance of abnormal CEC-DM interactions in triggering the vicious cycle of FECD pathogenesis. We will also review clinical characteristics, diagnostic tools, and current medical and surgical management options for FECD patients. These new paradigms in FECD pathogenesis present an opportunity to develop novel therapeutics for the treatment of FECD.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Corneal endothelium; Fuchs endothelial corneal dystrophy; Guttae; Mitochondria; Oxidative stress

Mesh:

Year:  2020        PMID: 32438095      PMCID: PMC7648733          DOI: 10.1016/j.preteyeres.2020.100863

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  544 in total

1.  The spectrum of beta ig-h3 gene mutations in Japanese patients with corneal dystrophy.

Authors:  S Yamamoto; M Okada; M Tsujikawa; H Morimura; N Maeda; H Watanabe; Y Inoue; Y Shimomura; S Kinoshita; Y Tano
Journal:  Cornea       Date:  2000-05       Impact factor: 2.651

2.  Antioxidant supplements prevent oxidation of cysteine/cystine redox in patients with age-related macular degeneration.

Authors:  Siobhan E Moriarty-Craige; Joanne Adkison; Michael Lynn; Gary Gensler; Susan Bressler; Dean P Jones; Paul Sternberg
Journal:  Am J Ophthalmol       Date:  2005-12       Impact factor: 5.258

3.  Expression of cell cycle-associated proteins in human and rabbit corneal endothelium in situ.

Authors:  N C Joyce; S E Navon; S Roy; J D Zieske
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-07       Impact factor: 4.799

Review 4.  Coenzyme Q10 in the Treatment of Corneal Edema in Kearns-Sayre: Is There an Application in Fuchs Endothelial Corneal Dystrophy?

Authors:  Jocelyn Kim; Anagha Medsinge; Bharesh Chauhan; Cara Wiest; Hannah Scanga; Rachael Monaghan; William H Moore; Ken K Nischal
Journal:  Cornea       Date:  2016-09       Impact factor: 2.651

5.  [Reduced production of aqueous humor in Fuch's corneal dystrophy].

Authors:  G Imre; J Bögi
Journal:  Klin Monbl Augenheilkd       Date:  1979-03       Impact factor: 0.700

Review 6.  Antisense oligonucleotides: the next frontier for treatment of neurological disorders.

Authors:  Carlo Rinaldi; Matthew J A Wood
Journal:  Nat Rev Neurol       Date:  2017-12-01       Impact factor: 42.937

7.  Role of hepatocyte growth factor in promoting the growth of human corneal endothelial cells stimulated by L-ascorbic acid 2-phosphate.

Authors:  Miwa Kimoto; Nobuyuki Shima; Masahiro Yamaguchi; Shiro Amano; Satoru Yamagami
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-09       Impact factor: 4.799

Review 8.  Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases.

Authors:  Naoki Okumura; Shigeru Kinoshita; Noriko Koizumi
Journal:  J Ophthalmol       Date:  2017-07-02       Impact factor: 1.909

9.  Association of polymorphisms in the intron of TCF4 gene to late-onset Fuchs endothelial corneal dystrophy: An Indian cohort study.

Authors:  Bhavna S Rao; Arokiasamy Tharigopala; Sudhir R Rachapalli; Rama Rajagopal; Nagasamy Soumittra
Journal:  Indian J Ophthalmol       Date:  2017-10       Impact factor: 1.848

10.  Quantitative Studies of Muscleblind Proteins and Their Interaction With TCF4 RNA Foci Support Involvement in the Mechanism of Fuchs' Dystrophy.

Authors:  Ziye Rong; Jiaxin Hu; David R Corey; V Vinod Mootha
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-09-03       Impact factor: 4.799

View more
  18 in total

Review 1.  Roles and Mechanisms of Regulated Necrosis in Corneal Diseases: Progress and Perspectives.

Authors:  Wanying Lin; Minting Chen; Yacouba Cissé; Xiaofeng Chen; Lang Bai
Journal:  J Ophthalmol       Date:  2022-05-23       Impact factor: 1.974

Review 2.  Diseases of the corneal endothelium.

Authors:  Lauren J Jeang; Curtis E Margo; Edgar M Espana
Journal:  Exp Eye Res       Date:  2021-02-14       Impact factor: 3.467

3.  Cell cycle re-entry and arrest in G2/M phase induces senescence and fibrosis in Fuchs Endothelial Corneal Dystrophy.

Authors:  Tomas L White; Neha Deshpande; Varun Kumar; Alex G Gauthier; Ula V Jurkunas
Journal:  Free Radic Biol Med       Date:  2021-01-06       Impact factor: 7.376

4.  Corneal Analysis with Swept Source Optical Coherence Tomography in Patients with Coexisting Cataract and Fuchs Endothelial Corneal Dystrophy.

Authors:  Anna Nowińska; Edyta Chlasta-Twardzik; Michał Dembski; Klaudia Ulfik-Dembska; Edward Wylęgała
Journal:  Diagnostics (Basel)       Date:  2021-02-02

5.  Small-Molecule Induction Promotes Corneal Endothelial Cell Differentiation From Human iPS Cells.

Authors:  Jie Chen; Qingjian Ou; Zhe Wang; Yifan Liu; Shuqin Hu; Yumeilan Liu; Haibin Tian; Jingying Xu; Furong Gao; Lixia Lu; Caixia Jin; Guo-Tong Xu; Hong-Ping Cui
Journal:  Front Bioeng Biotechnol       Date:  2021-12-15

6.  Long-term corneal recovery by simultaneous delivery of hPSC-derived corneal endothelial precursors and nicotinamide.

Authors:  Zongyi Li; Haoyun Duan; Yanni Jia; Can Zhao; Wenjing Li; Xin Wang; Yajie Gong; Chunxiao Dong; Bochao Ma; Shengqian Dou; Bin Zhang; Dongfang Li; Yihai Cao; Lixin Xie; Qingjun Zhou; Weiyun Shi
Journal:  J Clin Invest       Date:  2022-01-04       Impact factor: 14.808

7.  Incidence and Risk Factors of Corneal Endothelial Failure after Phacoemulsification in Patients with Fuchs Endothelial Corneal Dystrophy: A 13-Year Retrospective Cohort.

Authors:  Varintorn Chuckpaiwong; Sasin Muakkul; Prae Phimpho; Kaevalin Lekhanont; Passara Jongkhajornpong
Journal:  Clin Ophthalmol       Date:  2021-06-04

Review 8.  Nrf2: A unifying transcription factor in the pathogenesis of Fuchs' endothelial corneal dystrophy.

Authors:  Matthew Lovatt; Viridiana Kocaba; Dawn Jing Hui Neo; Yu Qiang Soh; Jodhbir S Mehta
Journal:  Redox Biol       Date:  2020-10-16       Impact factor: 11.799

9.  The Fuchs corneal dystrophy-associated CTG repeat expansion in the TCF4 gene affects transcription from its alternative promoters.

Authors:  Alex Sirp; Kristian Leite; Jürgen Tuvikene; Kaja Nurm; Mari Sepp; Tõnis Timmusk
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

Review 10.  TCF4-mediated Fuchs endothelial corneal dystrophy: Insights into a common trinucleotide repeat-associated disease.

Authors:  Michael P Fautsch; Eric D Wieben; Keith H Baratz; Nihar Bhattacharyya; Amanda N Sadan; Nathaniel J Hafford-Tear; Stephen J Tuft; Alice E Davidson
Journal:  Prog Retin Eye Res       Date:  2020-07-28       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.